News & Views

  • New Wave of Medtechs Join BioExel
    Pictured at the launch of the 2019 BioExel Programme at NUI Galway are: L-r back row: Bernice Crowley, BioExel, Barry Egan, Enterprise Ireland, Gillian Buckley, Western Development Commission, Sandra Ganly, Bioexel, Robert Rosenberg, BioExel Entrepreneur in Residence and Fiona Neary, BioExel. L-r front row: Maria Jennings, Enterprise Ireland and Donal Cahalane, Galway University Foundation, NUI Galway

New Wave of Medtechs Join BioExel

Feb 17 2019 Read 511 Times

The success of the inaugural 2018 NUI Galway BioExel programme led to the completion of a second round recruitment campaign, completed last December. A highcalibre of applications were reviewed from across the globe and the final eight companies are now immersed in the 2019 BioExel accelerator programme.
BioExel offers €95,000 in seed funding to successful applicants along with six-months of intensive training, mentoring, lab space and supported interactions with potential investors. The programme allows participants to build and commercially validate their technologies by working with existing entrepreneurial networks, mentors and management team.

BioExel is managed by MedTech Director, Dr Sandra Ganly, also a co-founder of BioInnovate Ireland and Senior Research Fellow in NUI Galway; and Fiona Neary, Commercial Director and co-founder of BioExel and Innovation Operations Manager at NUI Galway.

“BioExel’s mission is to act as an honest broker between Medtech start-ups and the investment community bridging the gap between technology de-risking and raising investment, said Fiona Neary. “BioExel has positioned itself as an internationally recognised Medtech accelerator with the reputation of significantly enhancing indigenous Medtech start-ups by providing attractive seed investment funding and a pipeline of next generation Medtech start-up’s for Ireland.”

Joe Healy, HPSU Divisional Manager, Enterprise Ireland, said: “Ireland has a growing reputation in MedTech start-ups and the west of Ireland is renowned globally as a top medical device cluster. The sector is an important contributor to our economic growth and BioExel is uniquely positioned to provide essential support for the new innovative start-ups in this sector. We are delighted to continue our support for the programme, and the companies who take part as they take their first steps towards building scale and expanding their reach.”

Joined by the funding partners last month at NUI Galway, the programme officially launched the new cohort of BioExel 2019 and enabled a great working session where partners and participants came together to share experiences and business opportunities.

A full list of the companies can be found at

Reader comments

Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.

Post a Comment

Digital Edition

Lab Asia April 2019

April 2019

In This Edition Articles - Mobile Affinity Sorbent Chromatography Of Proteins - Integration of MS and UV Data for Peak Tracking in HPLC Method Development - VMXm takes its First Users 'wher...

View all digital editions


SETAC Europe

May 26 2019 Helsinki, Finland

ASMS Conference

Jun 02 2019 Atlanta, GA, USA

Drug Discovery Summit

Jun 10 2019 Berlin, Germany

HPLC 2019

Jun 16 2019 Milan, Italy

View all events